Smoflipid and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Smoflipid (lipid injectable emulsion (soybean;mct;olive;fish)), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamins, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Dyspnea when taking Smoflipid. It is created by eHealthMe based on reports of 680 people who have side effects when taking Smoflipid from the FDA, and is updated regularly.

What is Smoflipid?

Smoflipid has active ingredients of lipid injectable emulsion (soybean;mct;olive;fish). eHealthMe is studying from 681 Smoflipid users. Check the latest studies of Smoflipid.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,725 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

680 people reported to have side effects when taking Smoflipid.
Among them, 27 people (3.97%) have Dyspnea.

Among these 27 people:

How long have people been on Smoflipid when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Smoflipid? *

female: 62.96 %
male: 37.04 %

What is the age of people who have Dyspnea when taking Smoflipid? *

What are other drugs people take besides Smoflipid? *

What are other side effects people have besides Dyspnea? *

Malaise (a feeling of general discomfort or uneasiness): 6 people, 22.22%
Chest Pain: 6 people, 22.22%
Fever: 5 people, 18.52%
Dizziness: 4 people, 14.81%
Nausea (feeling of having an urge to vomit): 4 people, 14.81%
Gallstones (stone formation by bile component): 4 people, 14.81%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 4 people, 14.81%
Device Related Infection: 4 people, 14.81%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 4 people, 14.81%
Cardiac Disorder: 4 people, 14.81%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 14.81%
Urinary Tract Infection: 3 people, 11.11%
Rectal Cancer (cancer of rectum): 3 people, 11.11%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 11.11%
Constipation: 3 people, 11.11%
Abdominal Pain: 3 people, 11.11%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 11.11%
Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 2 people, 7.41%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 2 people, 7.41%
Renal Cell Carcinoma (a kidney cancer): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Smoflipid and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Smoflipid:

Smoflipid (681 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

How severe was Dyspnea and when was it recovered:

Dyspnea in Smoflipid

Expand to all the drugs that have ingredients of lipid injectable emulsion (soybean;mct;olive;fish):

Dyspnea and drugs with ingredients of lipid injectable emulsion (soybean;mct;olive;fish)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Smoflipid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,725 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lipid injectable emulsion (soybean;mct;olive;fish) (the active ingredients of Smoflipid) and Smoflipid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.